Serology Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Test Type (Primary Serological Tests, Secondary Serological Tests, Tertiary Binding Tests), By Application (Rotavirus Infections, Hepatitis, HIV, Endotoxins, Therapeutic Drug Monitoring, Immunoglobin G, and Others), By Technology (ELISA, NAT, CLIA/CMIA and Others), By End Users (Hospitals, Diagnostic Laboratories, Blood Banks, Academic and Research Institutes, Others), and Region Forecast 2020-2031.

Serology Testing Market size was valued at US$ 4,908 million in 2024 and is expected to reach US$ 12,280 million by 2031, growing at a significant CAGR of 14.0% from 2025-2031. The serological testing is used to diagnose and analyse various types disease causing viruses like rota virus infection, HIV, endotoxins and other infectious disease causing viruses. The increasing incidence of COVID cases and increasing healthcare expenditure across the globe is expected to drive the growth of market over the forecasted years. In addition increasing investments in research and developments for COVID analysis kits and the government initiatives supporting the research of this segment is expected to boost the market growth at an significant rate over the forecasted period.

Furthermore, rising number of product launches and approval of serology testing kits are expected to fuel the market growth. However, shortage of serology testing kits, strict government regulations regarding the safety and high cost of serology testing kits are expected to hinder the market growth over the forecasted period. Moreover, increasing prevalence of diseases like HIV/AIDS, tuberculosis, hepatitis across the globe, increasing demand for ELISA test across the globe and increasing incidence of tuberculosis in geriatric population is expected to provide opportunities to the key market players in the growth of market over the forecasted period. Geographically, Asia Pacific region is expected to have a significant growth over the forecasted period due to the increasing awareness about the disease and high rate of infectious disease incidence in countries like India and China and rising per capita healthcare expenditure. The Europe region held the major market share in 2022 and is expected to dominate the global market in the forecasted years.

Key Developments:

• In April 2020, Accelerate Diagnostics and Biocheck collaborated to distribute SARS-COV-2 Antibody tests and MS-FAST Chemiluminescence Immunoassay Analyzer.
• In March 2020, Chembio Diagnostic Systems Inc launched their product ‘DPP Covid-19 serological test kit.